401 related articles for article (PubMed ID: 31140655)
1. Epidermolysis bullosa: Advances in research and treatment.
Prodinger C; Reichelt J; Bauer JW; Laimer M
Exp Dermatol; 2019 Oct; 28(10):1176-1189. PubMed ID: 31140655
[TBL] [Abstract][Full Text] [Related]
2. Translational perspectives to treat Epidermolysis bullosa-Where do we stand?
Prodinger C; Bauer JW; Laimer M
Exp Dermatol; 2020 Nov; 29(11):1112-1122. PubMed ID: 33043517
[TBL] [Abstract][Full Text] [Related]
3. The potential of gene therapy for recessive dystrophic epidermolysis bullosa.
Subramaniam KS; Antoniou MN; McGrath JA; Lwin SM
Br J Dermatol; 2022 Apr; 186(4):609-619. PubMed ID: 34862606
[TBL] [Abstract][Full Text] [Related]
4. Epidermolysis bullosa and cancer.
Mallipeddi R
Clin Exp Dermatol; 2002 Nov; 27(8):616-23. PubMed ID: 12472531
[TBL] [Abstract][Full Text] [Related]
5. Advances in Treatments for Epidermolysis Bullosa (EB): Emphasis on Stem Cell-Based Therapy.
Raoufinia R; Rahimi HR; Keyhanvar N; Moghbeli M; Abdyazdani N; Rostami M; Naghipoor K; Forouzanfar F; Foroudi S; Saburi E
Stem Cell Rev Rep; 2024 Jul; 20(5):1200-1212. PubMed ID: 38430362
[TBL] [Abstract][Full Text] [Related]
6. Investigational Treatments for Epidermolysis Bullosa.
Hou PC; Wang HT; Abhee S; Tu WT; McGrath JA; Hsu CK
Am J Clin Dermatol; 2021 Nov; 22(6):801-817. PubMed ID: 34292508
[TBL] [Abstract][Full Text] [Related]
7. Epidermolysis bullosa care in Austria and the Epidermolysis Bullosa House Austria.
Pohla-Gubo G; Hintner H
Dermatol Clin; 2010 Apr; 28(2):415-20, xv. PubMed ID: 20447517
[TBL] [Abstract][Full Text] [Related]
8. Epidermolysis bullosa: from fundamental molecular biology to clinical therapies.
Featherstone C
J Invest Dermatol; 2007 Feb; 127(2):256-9. PubMed ID: 17228301
[No Abstract] [Full Text] [Related]
9. Epidermolysis Bullosa-Associated Squamous Cell Carcinoma: From Pathogenesis to Therapeutic Perspectives.
Condorelli AG; Dellambra E; Logli E; Zambruno G; Castiglia D
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31739489
[TBL] [Abstract][Full Text] [Related]
10. Molecular therapies for inherited epidermolysis bullosa.
Has C
G Ital Dermatol Venereol; 2016 Aug; 151(4):397-402. PubMed ID: 27149615
[TBL] [Abstract][Full Text] [Related]
11. Multicentre consensus recommendations for skin care in inherited epidermolysis bullosa.
El Hachem M; Zambruno G; Bourdon-Lanoy E; Ciasulli A; Buisson C; Hadj-Rabia S; Diociaiuti A; Gouveia CF; Hernández-Martín A; de Lucas Laguna R; Dolenc-Voljč M; Tadini G; Salvatori G; De Ranieri C; Leclerc-Mercier S; Bodemer C
Orphanet J Rare Dis; 2014 May; 9():76. PubMed ID: 24884811
[TBL] [Abstract][Full Text] [Related]
12. Epidermolysis bullosa: scientific advances and therapeutic challenges.
Eady RA
J Dermatol; 2001 Nov; 28(11):638-40. PubMed ID: 11770723
[TBL] [Abstract][Full Text] [Related]
13. Squamous Cell Carcinoma in Patients with Inherited Epidermolysis Bullosa: Review of Current Literature.
Bonamonte D; Filoni A; De Marco A; Lospalluti L; Nacchiero E; Ronghi V; Colagrande A; Giudice G; Cazzato G
Cells; 2022 Apr; 11(8):. PubMed ID: 35456044
[TBL] [Abstract][Full Text] [Related]
14. Low-dose calcipotriol can elicit wound closure, anti-microbial, and anti-neoplastic effects in epidermolysis bullosa keratinocytes.
Guttmann-Gruber C; Tockner B; Scharler C; Hüttner C; Common JE; Tay ASL; Denil SLIJ; Klausegger A; Trost A; Breitenbach J; Schnitzhofer P; Hofbauer P; Wolkersdorfer M; Diem A; Laimer M; Strunk D; Bauer JW; Reichelt J; Lang R; Piñón Hofbauer J
Sci Rep; 2018 Sep; 8(1):13430. PubMed ID: 30194425
[TBL] [Abstract][Full Text] [Related]
15. Current topics in Epidermolysis bullosa: Pathophysiology and therapeutic challenges.
Natsuga K; Shinkuma S; Hsu CK; Fujita Y; Ishiko A; Tamai K; McGrath JA
J Dermatol Sci; 2021 Dec; 104(3):164-176. PubMed ID: 34916041
[TBL] [Abstract][Full Text] [Related]
16. Topical Diacerein Ointment for Epidermolysis Bullosa Simplex: A Review.
Limmer AL; Nwannunu CE; Shah R; Coleman K; Patel RR; Mui UN; Tyring SK
Skin Therapy Lett; 2019 May; 24(3):7-9. PubMed ID: 31095348
[TBL] [Abstract][Full Text] [Related]
17. Functional therapies for cutaneous wound repair in epidermolysis bullosa.
Peking P; Koller U; Murauer EM
Adv Drug Deliv Rev; 2018 Apr; 129():330-343. PubMed ID: 29248480
[TBL] [Abstract][Full Text] [Related]
18. The long and winding road that leads to a cure for epidermolysis bullosa.
Carulli S; Contin R; De Rosa L; Pellegrini G; De Luca M
Regen Med; 2013 Jul; 8(4):467-81. PubMed ID: 23826700
[TBL] [Abstract][Full Text] [Related]
19. Eye Involvement and Management in Inherited Epidermolysis Bullosa.
Bachir Y; Daruich A; Marie C; Robert MP; Bremond-Gignac D
Drugs; 2022 Aug; 82(12):1277-1285. PubMed ID: 36074321
[TBL] [Abstract][Full Text] [Related]
20. Multidisciplinary care for patients with epidermolysis bullosa from birth to adolescence: experience of one Italian reference center.
Retrosi C; Diociaiuti A; De Ranieri C; Corbeddu M; Carnevale C; Giancristoforo S; Marchili MR; Salvatori G; Atti MLCD; El Hachem M; Raponi M
Ital J Pediatr; 2022 Apr; 48(1):58. PubMed ID: 35414096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
